Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy:: Longitudinal study during pregnancy

被引:57
作者
Alegre, Estibaliz
Diaz-Lagares, Angel
LeMaoult, Joel
Lopez-Moratalla, Natalia
Carosella, Edgardo D.
Gonzalez, Alvaro [1 ]
机构
[1] Univ Navarra Clin, Dept Biochem, Pamplona, Spain
[2] Univ Navarra, Dept Biochem, Pamplona, Spain
[3] Hop St Louis, Inst Univ Hematol, CEA DSV DRM, Serv Rech Hemato Immunol, Paris, France
关键词
abortion; dendritic cells; HLA-G; monocytes; pregnancy;
D O I
10.1016/j.humimm.2007.04.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this work was to investigate the longitudinal evolution of plasmatic soluble HLA-G (sHLA-G: shed HLA-G1 plus HLA-G5) during pregnancy, and if peripheral maternal antigen presenting cells (APC) can be a source of sHLA-G. Blood samples were obtained from 45 volunteers during normal pregnancy, 8 of them monthly; from 8 pregnant volunteers in the first weeks of pregnancy who had later a miscarriage, and from 14 healthy nonpregnant control women. Monocytes obtained during pregnancy showed a moderately HLA-G cell surface expression and stimulation with interferon (IFN)-gamma increased this expression. Monocytes-derived dendritic cells obtained from pregnant women during the first and third trimester of pregnancy secreted more sHLA-G than those obtained from nonpregnant women. Plasmatic sHLA-G concentration in pregnant women was significatively higher than in nonpregnant women, with a peak in the third month. We can conclude that maternal APC are a source of sHLA-G. Women who experienced miscarriage had previously very tow or undetectable plasmatic sHLA-G Levels in the second month of pregnancy. Data suggest that undetectable sHLA-G could be a risk of complications. (c) 2007 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 45 条
[1]   HLA-G class I gene expression in normal and malignant hematopoietic cells [J].
Amiot, L ;
Onno, M ;
Drénou, B ;
Monvoisin, C ;
Fauchet, R .
HUMAN IMMUNOLOGY, 1998, 59 (08) :524-528
[2]   HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals [J].
Cabello, A ;
Rivero, A ;
Garcia, MJ ;
Lozano, JM ;
Torre-Cisneros, J ;
González, R ;
Dueñas, G ;
Galiani, MD ;
Camacho, A ;
Santamaria, M ;
Solana, R ;
Montero, C ;
Kindelán, JM ;
Peña, J .
HUMAN IMMUNOLOGY, 2003, 64 (11) :1045-1049
[3]   HLA-G molecules: from maternal-fetal tolerance to tissue acceptance [J].
Carosella, Edgardo D. ;
Moreau, Philippe ;
Le Maoult, Joel ;
Le Discorde, Magali ;
Dausset, Jean ;
Rouas-Freiss, Nathalie .
ADVANCES IN IMMUNOLOGY, VOL 81, 2003, 81 :199-+
[4]   Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NKCD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation [J].
Contini, P ;
Ghio, M ;
Poggi, A ;
Filaci, G ;
Indiveri, F ;
Ferrone, S ;
Puppo, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) :125-134
[5]   Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation [J].
Créput, C ;
Durrbach, A ;
Menier, C ;
Guettier, C ;
Samuel, D ;
Dausset, J ;
Charpentier, B ;
Carosella, ED ;
Rouas-Freiss, N .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :587-594
[6]   Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts [J].
Crisa, L ;
McMaster, MT ;
Ishii, JK ;
Fisher, SJ ;
Salomon, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :289-298
[7]   Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies [J].
Emmer, PM ;
Steegers, EAP ;
Kerstens, HMJ ;
Bulten, J ;
Nelen, WLDM ;
Boer, K ;
Joosten, I .
HUMAN REPRODUCTION, 2002, 17 (04) :1072-1080
[8]   Effect of nitric oxide in the differentiation of human monocytes to dendritic cells [J].
Fernández-Ruiz, V ;
González, A ;
López-Moratalla, N .
IMMUNOLOGY LETTERS, 2004, 93 (01) :87-95
[9]  
Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO
[10]  
2-#